Millennium Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Millennium Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,400	Closed	-$354K	–	7469
2021 Q1	$354K	Sell	9,400 -20,600	-69%	-$514K	﹤0.01%	5102
2020 Q4	$510K	Buy	+30,000	New	+$376K	﹤0.01%	4179

Millennium Management's FPRX Position: Q2 2021 in Review

Millennium Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 25,616 shares — an estimated $965K sold.

Millennium Management first reported a position in FPRX in Q1 2014 and held it in 25 quarters. The position peaked at $24M in Q1 2015. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Millennium Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Millennium Management sold 25,616 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $965K.
Millennium Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2014 and held it in 25 quarters.
Millennium Management's Five Prime Therapeutics, Inc. position peaked at $24M in Q1 2015.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.